The remainder of this review is dedicated to summarizing the pertinent functions of tGLI1-mediated SHH signaling in glioblastoma and breast cancer (Figure 3), two cancers in which tGLI1 activity has been validated, and how tGLI1 activity can be leveraged to devise novel treatments. This evidence concerns the gene SHH and breast carcinoma.